FTC sues big pharmacy benefit administrators about insulin selling prices The company brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of lifetime-preserving insulin medications. Hear the write-up 10 min This audio is auto-generated. Please let's know For https://aya-healthcare-address29483.blogsuperapp.com/31177137/not-known-facts-about-healthcare-news